Extracellular vesicles for drug delivery

Advanced Drug Delivery Reviews

Volumn 106, Issue , 2016, Pages 148-156

  Vader, Pieter ^a   Mol, Emma A ^a   Pasterkamp, Gerard ^a   Schiffelers, Raymond M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

biodistribution; drug delivery; exosomes; Extracellular vesicles; isolation; microvesicles; nanomedicine; targeting

Indexed keywords

DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; VEHICLES;

BIODISTRIBUTIONS; EXOSOMES; EXTRACELLULAR; ISOLATION; MICROVESICLES; TARGETING;

CELL ENGINEERING;

CELL INTERACTION; CELL ISOLATION; CELL SIZE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CIRCULATION TIME; DRUG DELIVERY SYSTEM; EXOSOME; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IMMUNE SYSTEM; LIGAND BINDING; LIPOSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA SEQUENCE; ULTRAFILTRATION; ANIMAL; METABOLISM; PROCEDURES;

DRUG CARRIER;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXTRACELLULAR VESICLES; HUMANS;

EID: 84960969467     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2016.02.006     Document Type: Review

References (80)

1. [1] Colombo, M., Raposo, G., Thery, C., Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30 (2014), 255–289.
2. [2] Gould, S.J., Raposo, G., As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracellular Vesicles, 2, 2013.
3. [3] Raposo, G., Stoorvogel, W., Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 200 (2013), 373–383.
4. [4] van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A.A., van Solinge, W.W., Wood, M.J.A., Schiffelers, R.M., Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. J. Control. Release 161 (2012), 635–644.
5. [5] Koppers-Lalic, D., Hackenberg, M., Bijnsdorp, I.V., van Eijndhoven, M.A.J., Sadek, P., Sie, D., Zini, N., Middeldorp, J.M., Ylstra, B., de Menezes, R.X., Wurdinger, T., Meijer, G.A., Pegtel, D.M., Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes. Cell Rep. 8 (2014), 1649–1658.
6. [6] Bolukbasi, M.F., Mizrak, A., Ozdener, G.B., Madlener, S., Strobel, T., Erkan, E.P., Fan, J.B., Breakefield, X.O., Saydam, O., miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles. Mol. Ther.–Nucleic Acids, 1, 2012.
7. [7] Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
8. [8] Ratajczak, J., Miekus, K., Kucia, M., Zhang, J., Reca, R., Dvorak, P., Ratajczak, M.Z., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20 (2006), 847–856.
9. [9] Pegtel, D.M., Cosmopoulos, K., Thorley-Lawson, D.A., van Eijndhoven, M.A., Hopmans, E.S., Lindenberg, J.L., de Gruijl, T.D., Wurdinger, T., Middeldorp, J.M., Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 6328–6333.
10. [10] Skog, J., Wurdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T. Jr., Carter, B.S., Krichevsky, A.M., Breakefield, X.O., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10 (2008), 1470–1476.
11. [11] Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., Rak, J., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10 (2008), 619–624.
12. [12] Caby, M.P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., Bonnerot, C., Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 17 (2005), 879–887.
13. [13] Pisitkun, T., Shen, R.F., Knepper, M.A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 13368–13373.
14. [14] Ogawa, Y., Miura, Y., Harazono, A., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., Yamaguchi, T., Toda, T., Endo, T., Tsubuki, M., Yanoshita, R., Proteomic Analysis of Two Types of Exosomes in Human Whole Saliva. Biol. Pharm. Bull. 34 (2011), 13–23.
15. [15] Urbanelli, L., Buratta, S., Sagini, K., Ferrara, G., Lanni, M., Emiliani, C., Exosome-based strategies for Diagnosis and Therapy, Recent patents on CNS drug discovery. 10, 2015, 10–27.
16. [16] Lasser, C., Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle. Expert. Opin. Biol. Ther. 15 (2015), 103–117.
17. [17] Time to deliver. Nat. Biotechnol., 32, 2014, 961.
18. [18] Tsui, N.B.Y., Ng, E.K.O., Lo, Y.M.D., Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin. Chem. 48 (2002), 1647–1653.
19. [19] Alvarez-Erviti, L., Seow, Y.Q., Yin, H.F., Betts, C., Lakhal, S., Wood, M.J.A., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol., 29, 2011 (341-U179).
20. [20] Zhuang, X.Y., Xiang, X.Y., Grizzle, W., Sun, D.M., Zhang, S.Q., Axtell, R.C., Ju, S.W., Mu, J.Y., Zhang, L.F., Steinman, L., Miller, D., Zhang, H.G., Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain. Mol. Ther. 19 (2011), 1769–1779.
21. [21] Marcus, M.E., Leonard, J.N., FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver. Pharmaceuticals (Basel) 6 (2013), 659–680.
22. [22] Escudier, B., Dorval, T., Chaput, N., Andre, F., Caby, M.P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., Boccaccio, C., Bonnerot, C., Dhellin, O., Movassagh, M., Piperno, S., Robert, C., Serra, V., Valente, N., Le Pecq, J.B., Spatz, A., Lantz, O., Tursz, T., Angevin, E., Zitvogel, L., Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med., 3, 2005, 10.
23. [23] Morse, M.A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T.M., Valente, N., Shreeniwas, R., Sutton, M.A., Delcayre, A., Hsu, D.H., Le Pecq, J.B., Lyerly, H.K., A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med., 3, 2005, 9.
24. [24] Dai, S., Wei, D., Wu, Z., Zhou, X., Wei, X., Huang, H., Li, G., Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 16 (2008), 782–790.
25. [25] Lener, T., Gimona, M., Aigner, L., Borger, V., Buza s, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F.A., Del Portillo, H.A., O'Driscoll, L., Fais, S., Falcon-Perez, J.M., Felderhoff-Mueser, U., Fraile, L., Gho, Y.S., Gorgens, A., Gupta, R.C., Hendrix, A., Hermann, D.M., Hill, A.F., Hochberg, F., Horn, P.A., de Kleijn, D., Kordelas, L., Kramer, B.W., Kramer-Albers, E.M., Laner-Plamberger, S., Laitinen, S., Leonardi, T., Lorenowicz, M.J., Lim, S.K., Lotvall, J., Maguire, C.A., Marcilla, A., Nazarenko, I., Ochiya, T., Patel, T., Pedersen, S., Pocsfalvi, G., Pluchino, S., Quesenberry, P., Reischl, I.G., Rivera, F.J., Sanzenbacher, R., Schallmoser, K., Slaper-Cortenbach, I., Strunk, D., Tonn, T., Vader, P., van Balkom, B.W., Wauben, M., Andaloussi, S.E., Thery, C., Rohde, E., Giebel, B., Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J. Extracellular Vesicles, 4, 2015, 30087.
26. [26] Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol., 2006, 22 (Chapter 3, Unit 3).
27. [27] Aalberts, M., van Dissel-Emiliani, F.M., van Adrichem, N.P., van Wijnen, M., Wauben, M.H., Stout, T.A., Stoorvogel, W., Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol. Reprod., 86, 2012, 82.
28. [28] Taylor, D.D., Shah, S., Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods 87 (2015), 3–10.
29. [29] Clayton, A., Court, J., Navabi, H., Adams, M., Mason, M.D., Hobot, J.A., Newman, G.R., Jasani, B., Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 247 (2001), 163–174.
30. [30] Ashcroft, B.A., de Sonneville, J., Yuana, Y., Osanto, S., Bertina, R., Kuil, M.E., Oosterkamp, T.H., Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics. Biomed. Microdevices 14 (2012), 641–649.
31. [31] Lamparski, H.G., Metha-Damani, A., Yao, J.Y., Patel, S., Hsu, D.H., Ruegg, C., Le Pecq, J.B., Production and characterization of clinical grade exosomes derived from dendritic cells. J. Immunol. Methods 270 (2002), 211–226.
32. [32] Heinemann, M.L., Ilmer, M., Silva, L.P., Hawke, D.H., Recio, A., Vorontsova, M.A., Alt, E., Vykoukal, J., Benchtop isolation and characterization of functional exosomes by sequential filtration. J. Chromatogr. A 1371 (2014), 125–135.
33. [33] Boing, A.N., van der Pol, E., Grootemaat, A.E., Coumans, F.A., Sturk, A., Nieuwland, R., Single-step isolation of extracellular vesicles by size-exclusion chromatography. J. Extracellular Vesicles, 3, 2014.
34. [34] Welton, J.L., Webber, J.P., Botos, L.A., Jones, M., Clayton, A., Ready-made chromatography columns for extracellular vesicle isolation from plasma. J. Extracellular Vesicles, 4, 2015, 27269.
35. [35] Nordin, J.Z., Lee, Y., Vader, P., Mager, I., Johansson, H.J., Heusermann, W., Wiklander, O.P., Hallbrink, M., Seow, Y., Bultema, J.J., Gilthorpe, J., Davies, T., Fairchild, P.J., Gabrielsson, S., Meisner-Kober, N.C., Lehtio, J., Smith, C.I., Wood, M.J., El Andaloussi, S., Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties. Nanomed.: Nanotechnol., Biol. Med. 11:4 (May 2015), 879–883.
36. [36] Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001), 494–498.
37. [37] Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., Ochiya, T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285 (2010), 17442–17452.
38. [38] Kosaka, N., Iguchi, H., Yoshioka, Y., Hagiwara, K., Takeshita, F., Ochiya, T., Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem. 287 (2012), 1397–1405.
39. [39] Pan, Q., Ramakrishnaiah, V., Henry, S., Fouraschen, S., de Ruiter, P.E., Kwekkeboom, J., Tilanus, H.W., Janssen, H.L., van der Laan, L.J., Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 61 (2012), 1330–1339.
40. [40] Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., Sun, Q., Wang, K., Ba, Y., Wang, Q., Wang, D., Yang, J., Liu, P., Xu, T., Yan, Q., Zhang, J., Zen, K., Zhang, C.Y., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39 (2010), 133–144.
41. [41] Akao, Y., Iio, A., Itoh, T., Noguchi, S., Itoh, Y., Ohtsuki, Y., Naoe, T., Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 19 (2011), 395–399.
42. [42] Batagov, A.O., Kuznetsov, V.A., Kurochkin, I.V., Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics, 12(Suppl. 3), 2011, S18.
43. [43] Pascucci, L., Cocce, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Vigano, L., Locatelli, A., Sisto, F., Doglia, S.M., Parati, E., Bernardo, M.E., Muraca, M., Alessandri, G., Bondiolotti, G., Pessina, A., Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery. J. Control. Release 192 (2014), 262–270.
44. [44] Tang, K., Zhang, Y., Zhang, H.F., Xu, P.W., Liu, J., Ma, J.W., Lv, M., Li, D.P., Katirai, F., Shen, G.X., Zhang, G.M., Feng, Z.H., Ye, D.Y., Huang, B., Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat. Commun., 3, 2012.
45. [45] Lee, J., Kim, J., Jeong, M., Lee, H., Goh, U., Kim, H., Kim, B., Park, J.H., Liposome-Based Engineering of Cells To Package Hydrophobic Compounds in Membrane Vesicles for Tumor Penetration. Nano Lett. 15 (2015), 2938–2944.
46. [46] Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G., A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18 (2010), 1606–1614.
47. [47] Saari, H., Lazaro-Ibanez, E., Viitala, T., Vuorimaa-Laukkanen, E., Siljander, P., Yliperttula, M., Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J. Control. Release 220 (2015), 727–737.
48. [48] Kim, M.S., Haney, M.J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N.L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., Hingtgen, S.D., Kabanov, A.V., Batrakova, E.V., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed.: Nanotechnol., Biol. Med., Nov. 14 2015, 10.1016/j.nano.2015.10.012 [Epub ahead of print].
49. [49] Wahlgren, J., De, L.K.T., Brisslert, M., Vaziri Sani, F., Telemo, E., Sunnerhagen, P., Valadi, H., Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res., 40, 2012, e130.
50. [50] Kooijmans, S.A., Stremersch, S., Braeckmans, K., de Smedt, S.C., Hendrix, A., Wood, M.J., Schiffelers, R.M., Raemdonck, K., Vader, P., Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J. Control. Release 172 (2013), 229–238.
51. [51] Stoicheva, N.G., Hui, S.W., Electrofusion of cell-size liposomes. Biochim. Biophys. Acta 1195 (1994), 31–38.
52. [52] Hood, J.L., Scott, M.J., Wickline, S.A., Maximizing exosome colloidal stability following electroporation. Anal. Biochem. 448 (2014), 41–49.
53. [53] Haney, M.J., Klyachko, N.L., Zhao, Y., Gupta, R., Plotnikova, E.G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A.V., Batrakova, E.V., Exosomes as drug delivery vehicles for Parkinson's disease therapy. J. Control. Release 207 (2015), 18–30.
54. [54] Fuhrmann, G., Serio, A., Mazo, M., Nair, R., Stevens, M.M., Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J. Control. Release 205 (2015), 35–44.
55. [55] Wiklander, O.P., Nordin, J.Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mager, I., Vader, P., Lee, Y., Sork, H., Seow, Y., Heldring, N., Alvarez-Erviti, L., Smith, C.E., Le Blanc, K., Macchiarini, P., Jungebluth, P., Wood, M.J., Andaloussi, S.E., Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracellular Vesicles, 4, 2015, 26316.
56. [56] Lai, C.P., Mardini, O., Ericsson, M., Prabhakar, S., Maguire, C.A., Chen, J.W., Tannous, B.A., Breakefield, X.O., Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano 8 (2014), 483–494.
57. [57] Imai, T., Takahashi, Y., Nishikawa, M., Kato, K., Morishita, M., Yamashita, T., Matsumoto, A., Charoenviriyakul, C., Takakura, Y., Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J. Extracellular Vesicles, 4, 2015, 26238.
58. [58] Bala, S., Csak, T., Momen-Heravi, F., Lippai, D., Kodys, K., Catalano, D., Satishchandran, A., Ambros, V., Szabo, G., Biodistribution and function of extracellular miRNA-155 in mice. Sci. Rep., 5, 2015, 10721.
59. [59] van der Meel, R., Fens, M.H.A.M., Vader, P., van Solinge, W.W., Eniola-Adefeso, O., Schiffelers, R.M., Extracellular vesicles as drug delivery systems: Lessons from the liposome field. J. Control. Release 195 (2014), 72–85.
60. [60] Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M.W., Anchordoquy, T.J., Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J. Control. Release 199 (2015), 145–155.
61. [61] Kooijmans, S.A., Fliervoet, L.A., van der Meel, R., Fens, M.H., Heijnen, H.F., van Bergen En Henegouwen, P.M., Vader, P., Schiffelers, R.M., PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J. Control. Release 224 (2016), 77–85.
62. [62] Moghimi, S.M., Hamad, I., Liposome-mediated triggering of complement cascade. J. Liposome Res. 18 (2008), 195–209.
63. [63] Clayton, A., Harris, C.L., Court, J., Mason, M.D., Morgan, B.P., Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33 (2003), 522–531.
64. [64] Whitehead, B., Wu, L., Hvam, M.L., Aslan, H., Dong, M., Dyrskjot, L., Ostenfeld, M.S., Moghimi, S.M., Howard, K.A., Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness. J. Extracellular Vesicles, 4, 2015, 29685.
65. [65] Chaput, N., Taieb, J., Andre, F., Zitvogel, L., The potential of exosomes in immunotherapy. Expert. Opin. Biol. Ther. 5 (2005), 737–747.
66. [66] Hellwinkel, J.E., Redzic, J.S., Harland, T.A., Gunaydin, D., Anchordoquy, T.J., Graner, M.W., Glioma-derived extracellular vesicles selectively suppress immune responses. Neuro Oncol., Sep. 18 2015 [Epub ahead of print].
67. [67] Monguio-Tortajada, M., Lauzurica-Valdemoros, R., Borras, F.E., Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. Front. Immunol., 5, 2014, 416.
68. [68] Kordelas, L., Rebmann, V., Ludwig, A.K., Radtke, S., Ruesing, J., Doeppner, T.R., Epple, M., Horn, P.A., Beelen, D.W., Giebel, B., MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28 (2014), 970–973.
69. [69] Costa-Silva, B., Aiello, N.M., Ocean, A.J., Singh, S., Zhang, H., Thakur, B.K., Becker, A., Hoshino, A., Mark, M.T., Molina, H., Xiang, J., Zhang, T., Theilen, T.M., Garcia-Santos, G., Williams, C., Ararso, Y., Huang, Y., Rodrigues, G., Shen, T.L., Labori, K.J., Lothe, I.M., Kure, E.H., Hernandez, J., Doussot, A., Ebbesen, S.H., Grandgenett, P.M., Hollingsworth, M.A., Jain, M., Mallya, K., Batra, S.K., Jarnagin, W.R., Schwartz, R.E., Matei, I., Peinado, H., Stanger, B.Z., Bromberg, J., Lyden, D., Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17 (2015), 816–826.
70. [70] Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G.J., Wei, J., Nie, G., A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35 (2014), 2383–2390.
71. [71] Hung, M.E., Leonard, J.N., Stabilization of exosome-targeting peptides via engineered glycosylation. J. Biol. Chem. 290 (2015), 8166–8172.
72. [72] Ohno, S., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., Gotoh, N., Kuroda, M., Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21 (2013), 185–191.
73. [73] Widder, K.J., Senyei, A.E., Ranney, D.F., Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Adv. Pharmacol. Chemother. 16 (1979), 213–271.
74. [74] Senyei, A.E., Reich, S.D., Gonczy, C., Widder, K.J., In vivo kinetics of magnetically targeted low-dose doxorubicin. J. Pharm. Sci. 70 (1981), 389–391.
75. [75] Silva, A.K., Luciani, N., Gazeau, F., Aubertin, K., Bonneau, S., Chauvierre, C., Letourneur, D., Wilhelm, C., Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting. Nanomed.: Nanotechnol., Biol. Med. 11 (2015), 645–655.
76. [76] Maeda, H., Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Control. Release 164 (2012), 138–144.
77. [77] Mizrak, A., Bolukbasi, M.F., Ozdener, G.B., Brenner, G.J., Madlener, S., Erkan, E.P., Strobel, T., Breakefield, X.O., Saydam, O., Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol. Ther. 21 (2013), 101–108.
78. [78] Zhang, Y., Li, L., Yu, J., Zhu, D., Li, X., Gu, H., Zhang, C.Y., Zen, K., Microvesicle-mediated delivery of transforming growth factor beta1 siRNA for the suppression of tumor growth in mice. Biomaterials 35 (2014), 4390–4400.
79. [79] Jang, S.C., Kim, O.Y., Yoon, C.M., Choi, D.S., Roh, T.Y., Park, J., Nilsson, J., Lotvall, J., Kim, Y.K., Gho, Y.S., Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7 (2013), 7698–7710.
80. [80] Yoon, J., Jo, W., Jeong, D., Kim, J., Jeong, H., Park, J., Generation of nanovesicles with sliced cellular membrane fragments for exogenous material delivery. Biomaterials 59 (2015), 12–20.